Description
Release form
Solution for intravenous and intramuscular administration of 50 mg / ml and 100 mg / ml.
2 ml in ampoules of glass 1 hydrolytic class with a color marking ring. 5 ampoules in a blister strip packaging made of PVC film without foil.
2 blister packs of 5 ampoules together with instructions for use are placed in a pack of cardboard.
Pharmacological action of
Nootropic agent that dilates the vessels of the brain. It has a tranquilizing and mild psychostimulating effect, antiplatelet and antioxidant effects. It improves the functional state of the brain due to the normalization of tissue metabolism and the effect on cerebral circulation (increases the volumetric and linear velocity of cerebral blood flow, has a vasodilating, antiplatelet, antioxidant effect, improves microcirculation). With a course admission, it increases physical and mental performance, reduces headache, improves memory, normalizes sleep, and helps to reduce or disappear feelings of anxiety, tension, fear, emotional restraint. Helps to restore central motor and speech disorders of vascular or traumatic origin. Improves blood circulation in the vessels of the retina and optic nerve.
Pharmacokinetics: Absorption – fast and complete with any route of administration. Penetrates through the blood-brain barrier, is retained in the tissues of the body for a long time. Bioavailability is 50-88%. It is excreted mainly by the kidneys unchanged. The elimination half-life is 0.51 hours.
Indications
Adults:
chronic cerebrovascular insufficiency (discirculatory encephalopathy, consequences of cerebrovascular accident), the state after traumatic brain injury, autonomic dystonia syndrome, as part of the complex therapy of depressive disorders of various origins in the elderly.
as part of a comprehensive treatment for chronic alcoholism (reduction of asthenic, asthenoneurotic, postpsychotic, pre-relapse conditions in alcoholic encephalopathy).
as part of the complex treatment of primary open-angle glaucoma with compensated intraocular pressure (to stabilize visual function).
as part of the complex treatment of autonomic dystonia syndrome, accompanied by anxiety, fear, increased irritability, asthenia, emotional lability.
to improve the tolerance of physical and mental stress, increase stress resistance (persons under intense and extreme conditions of activity to restore the physical performance of athletes, to increase resistance to physical and mental stress).
Children older than 3 years and adults in urological practice with urinary disorders to improve the adaptive function of the bladder (decrease in detrusor hypoxia).
Special instructions
Perhaps a negative effect of the drug on the performance of potentially hazardous activities that require special attention and quick response (driving, working with moving machinery, etc.).
Effect on the ability to drive vehicles and mechanisms: During treatment, care should be taken when driving vehicles and engaging in other potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions.
Ingredients
sodium ammogloid 100 mg mg and 100 mg sodium hydrochloric acid solution – up to pH from 6.7 to 8.0
Water for injection – up to 1 ml
Dosage and administration
Intravenously drip or stream (slowly), intramuscularly.
Before dropwise administration, the contents of the ampoule are dissolved in 200 ml of a 0.9% sodium chloride solution.
In case of chronic cerebrovascular insufficiency: 100-200 mg is administered once a day for 10 days intravenously, then intramuscularly. The course of treatment is 15-30 days. When the condition improves, they switch to oral forms in a daily dose of 50-150 mg. Repeated course – after 5-6 months.
As part of complex therapy in the treatment of depressive conditions of the elderly: 50-200 mg per day are administered for 10-15 days.
In the treatment of chronic alcoholism, 100 mg per day is administered in a course of 6-15 days.
To restore working capacity at high loads, 200 mg are administered in a daily dose for 10-15 days, for athletes – in the same dose for 14 days of the training period.
As part of the complex treatment of autonomic dystonia syndrome, 100-200 mg are prescribed for 10-15 days.
In the complex treatment of primary open-angle glaucoma, 100-200 mg per day is administered for 10 days.
In the treatment of urination disorders: 100 mg intramuscularly (for children from 3 to 10 years old), 200 mg per day (for children over 11 years old and adults).
Side effects
Decreased blood pressure, dizziness, headache, slight nausea, irritability, agitation, anxiety, allergic reactions (skin rash, itching).
Drug Interactions
Shortens the effects of barbiturates, enhances the effects of narcotic analgesics.
Overdose
Increased severity of dose-dependent symptoms of side effects. The treatment is symptomatic.
Storage conditions
In a dark place at a temperature of no higher than 25 ° C.
Keep out of the reach of children.
The Expiration of
is 3 years.
Deystvuyuschee substances
Nykotynoyl gamma amynomaslyanaya acid
Form of Treatment
simply entails dlya inaektsiy and infusing
